Merck & Co. Inc. buy Truist Financial Co.
Start price
02.02.24
/
50%
€117.20
Target price
02.02.25
€128.74
Performance (%)
-8.17%
Price
29.08.24
€106.20
Summary
This prediction is currently active. With a performance of -8.17%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. Dividends of €1.42 are taken into consideration when calculating the performance. This prediction currently runs until 02.02.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | 1.143% | 1.143% |
iShares Core DAX® | 2.147% | 2.681% |
iShares Nasdaq 100 | -0.578% | -0.816% |
iShares Nikkei 225® | 0.635% | 3.079% |
iShares S&P 500 | 0.746% | 0.171% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Truist Financial Co. from $122.00 to $139.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€122.60
26.04.24
26.04.24
€133.79
26.04.25
26.04.25
-12.79%
29.08.24
29.08.24
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€122.00
28.03.24
28.03.24
€131.41
28.03.25
28.03.25
-12.36%
29.08.24
29.08.24
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€98.10
06.10.23
06.10.23
€115.13
06.10.24
06.10.24
10.42%
29.08.24
29.08.24